Genetic modifiers of atherosclerosis in mice

被引:121
作者
Knowles, JW
Maeda, N
机构
[1] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA
关键词
apoE; LDL receptor; hypertension; inflammation; diabetes;
D O I
10.1161/01.ATV.20.11.2336
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis is a complex, multifactorial disease with both genetic and environmental determinants. Experimental investigation of the effects of these determinants on the development and progression of atherosclerosis has been greatly facilitated by the use of targeted mouse models of the disease, particularly those resulting from the absence of functional genes for apolipoprotein E or the low density lipoprotein receptor (LDLR). This review focuses on the influence on atherosclerosis of combining apoE or LDLR deficiencies with factors affecting atherogenesis, including (1) inflammatory processes, (2) glucose metabolism, (3) blood pressure, and (4) coagulation and fibrinolysis. We also discuss the general problem of using the mouse to test the effects on atherogenesis of human polymorphic variations and future ways of enhancing the usefulness of these mouse models.
引用
收藏
页码:2336 / 2345
页数:10
相关论文
共 114 条
[41]   Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis [J].
Hofker, MH ;
van Vlijmen, BJM ;
Havekes, LM .
ATHEROSCLEROSIS, 1998, 137 (01) :1-11
[42]   HYPERCHOLESTEROLEMIA IN LOW-DENSITY-LIPOPROTEIN RECEPTOR KNOCKOUT MICE AND ITS REVERSAL BY ADENOVIRUS-MEDIATED GENE DELIVERY [J].
ISHIBASHI, S ;
BROWN, MS ;
GOLDSTEIN, JL ;
GERARD, RD ;
HAMMER, RE ;
HERZ, J .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) :883-893
[43]   MASSIVE XANTHOMATOSIS AND ATHEROSCLEROSIS IN CHOLESTEROL-FED LOW-DENSITY-LIPOPROTEIN RECEPTOR-NEGATIVE MICE [J].
ISHIBASHI, S ;
GOLDSTEIN, JL ;
BROWN, MS ;
HERZ, J ;
BURNS, DK .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :1885-1893
[44]   Role of group II secretory phospholipase A2 in atherosclerosis -: 1.: Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2 [J].
Ivandic, B ;
Castellani, LW ;
Wang, XP ;
Qiao, JH ;
Mehrabian, M ;
Navab, M ;
Fogelman, AM ;
Grass, DS ;
Swanson, ME ;
de Beer, MC ;
de Beer, F ;
Lusis, AJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (05) :1284-1290
[45]   Absence of P-selectin delays fatty streak formation in mice [J].
Johnson, RC ;
Chapman, SM ;
Dong, ZM ;
Ordovas, JM ;
Mayadas, TN ;
Herz, J ;
Hynes, RO ;
Schaefer, EJ ;
Wagner, DD .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) :1037-1043
[46]   DIABETES AND CARDIOVASCULAR-DISEASE - FRAMINGHAM-STUDY [J].
KANNEL, WB ;
MCGEE, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (19) :2035-2038
[47]   Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis [J].
Keidar, S ;
Attias, J ;
Heinrich, R ;
Coleman, R ;
Aviram, M .
ATHEROSCLEROSIS, 1999, 146 (02) :249-257
[48]   The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice [J].
Keidar, S ;
Attias, J ;
Smith, J ;
Breslow, JL ;
Hayek, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (03) :622-625
[49]   Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2 [J].
Kido, Y ;
Burks, DJ ;
Withers, D ;
Bruning, JC ;
Kahn, CR ;
White, MF ;
Accili, D .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (02) :199-205
[50]   Apo E structure determines VLDL clearance and atherosclerosis risk in mice [J].
Knouff, C ;
Hinsdale, ME ;
Mezdour, H ;
Altenburg, MK ;
Watanabe, M ;
Quarfordt, SH ;
Sullivan, PM ;
Maeda, N .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) :1579-1586